Search Results
Feb 25, 2026, 00:02 ET Children's Hospital of Philadelphia Marks One-Year Anniversary of World's First Personalized CRISPR Gene Therapy for Child with Rare Genetic Disease
Rebecca Ahrens-Nicklas, MD, PhD, director of CHOP's
More news about: Children's Hospital of Philadelphia
Feb 24, 2026, 21:00 ET Barshop Institute to receive up to $38 million from ARPA-H, anchoring UT San Antonio as a national leader in aging and healthy longevity science
decade of leadership in aging science."For decades, the Barshop Institute has helped define the biology of aging," said Jennifer Sharpe Potter, PhD, MPH, senior executive vice president for research and innovation for UT San Antonio. "Today, that foundational science has matured into a national clinical
More news about: UT Health San Antonio
Feb 24, 2026, 17:04 ET National Event Series "Parkinson's IQ + You" Arrives in Southern Nevada to Educate and Empower Parkinson's Disease Patients and Care Partners
Latest in Parkinson's Research," led by Maggie Kuhl, MJFF's vice president of patient engagement will feature a discussion with Ariana Farrand, PhD, MJFF senior scientific portfolio manager; Odinachi Oguh, MD, Cleveland Clinic Lou Rovo Center for Brain Health — Las Vegas; and Irfan Qureshi, MD, Chief
More news about: The Michael J. Fox Foundation for Parkinson's Research
Feb 24, 2026, 13:50 ET Base Molecular Resonance™ Technologies Announces Transformational Advancement in Quantum Resonance Detection
category of breakthrough science that has the potential to be Nobel Prize-worthy in its long-term impact." - Professor Philippe B. Wilson, PhD Through intensive experimental validation and enhancements of the basic understanding of the underlying physics architecture, BMRT has materially
More news about: Base Molecular Resonance Technologies, LLC
Feb 24, 2026, 12:15 ET Illumina launches TruPath Genome, setting a new standard in genomic insight
TruPath Genome, we are pushing the boundaries of genomics and setting a new standard for genetic and rare disease research," said Steve Barnard, PhD, chief technology officer of Illumina. "In rare disease, you're often looking for a variant needle in a genomic haystack—and comprehensiveness,
More news about: Illumina, Inc.
Feb 24, 2026, 11:24 ET Solve M.E. Funds GLP-1 and Immune Target Studies to Accelerate ME/CFS and Long Covid Breakthroughs
The second, led by Professors Liisa Selin, MD, PhD, (Professor, Dept of Pathology, University of Massachusetts Chan Medical School), Roshan Kumar, PhD (Executive Director, Head of Translational Medicine at HiFiBiO Therapeutics), and Ayano Kohlgruber, PhD (Assistant Professor at Boston Children's Hospital),
More news about: Solve M.E.
Feb 24, 2026, 11:05 ET GRAIL Launches AI-Native Platform to Reduce Researchers' Administrative Work
with the full reality of scientific work and builds AI around that workflow from the ground up, a focus that has driven rapid organic adoption among PhD students, faculty, and nonprofit researchers.Built Around Established Scientific StandardsRather than adapting general-purpose
More news about: GRAIL
Feb 24, 2026, 10:00 ET Bloom Science Initiates Phase 1b Obesity Trial of BL-001, Advancing a Differentiated Approach Beyond GLP-1
pharmaceutical product."Millions of patients remain untreated because existing therapies do not align with their preferences," said Christopher Reyes, PhD, Chief Executive Officer of Bloom Science. "BL-001 is designed to change that, delivering the metabolic benefits of the ketogenic diet in a daily oral
More news about: Bloom Science, Inc.
Feb 24, 2026, 09:17 ET International expert panel reveals the 2026 Lionel Gelber Prize Shortlist
Global History by Sven Beckert (Penguin Press)Sven Beckert is the Laird Bell Professor of History at Harvard University. Holding a PhD from Columbia University, he has written widely on the economic, social, and political history of capitalism. His book Empire of Cotton won the
More news about: The Lionel Gelber Prize
Feb 24, 2026, 09:15 ET Newport Healthcare Recognizes National Eating Disorders Awareness Week by Collaborating with Field's Top Professional Associations
often underrecognized relationship between trauma and eating disorders. The panel featured Newport Healthcare's Medical Director Mirela Loftus, MD, PhD; National Director of Eating Disorder Programs Kara Becker, LMFT, CEDS; National Nutrition Manager Annaliese DiFabbio, RD, CEDS; and National Director
More news about: Newport Healthcare
Feb 24, 2026, 09:10 ET Global Clean Energy Acquires Flamelit to Accelerate AI-Driven Resilience
expertise positions GCEI to lead in mission-critical applications from utilities protection to environmental health intelligence. With Tom Roderick, PhD, Chief AI Officer, we're ready to scale these solutions and drive real-world resilience."Flamelit's portfolio includes innovations like AI algorithms
More news about: Global Clean Energy Inc.
Feb 24, 2026, 09:05 ET New Research Finds Heart Health Benefits in Combining Mango and Avocado Daily
strategies to help reduce cardiovascular disease risk, particularly in vulnerable populations like those with prediabetes," said Britt Burton-Freeman, PhD, Principal Investigator and Professor at Illinois Tech. "It's an encouraging message: small, nutrient-dense additions—like incorporating avocado and
More news about: The National Mango Board
Feb 24, 2026, 09:03 ET Xtressé™ Launches the First Stress-Adaptive Hair Therapy System Combining At-Home Daily Ritual with an Exclusive Medical Practice Treatment
and stimulate the scalp."Every component of this system was engineered based on cellular response data, not trends," said Trillitye Paullin, PhD, Co-Founder of Xtressé™. " FR Concentrate serum is powered by a scientifically optimized oligopeptide ratio and shown to produce a 165% increase in proliferation
More news about: Xtressé™
Feb 24, 2026, 09:00 ET International expert panel reveals the 2026 Lionel Gelber Prize Shortlist
Global History by Sven Beckert (Penguin Press)Sven Beckert is the Laird Bell Professor of History at Harvard University. Holding a PhD from Columbia University, he has written widely on the economic, social, and political history of capitalism. His book Empire of Cotton won the
More news about: The Lionel Gelber Prize
Feb 24, 2026, 09:00 ET Huntington Bank's 2026 Beyond Business Report Reveals Rebounding Optimism, Readiness Gaps for Business Owners
officers and financial decision-makers and features expert insights from Dan Griffith, director of wealth strategy at Huntington, and Olu Omodunbi, PhD, chief economist for Huntington Private Bank.
More news about: Huntington National Bank
Feb 24, 2026, 08:30 ET Therna Biosciences Appoints Biotech Veteran Devyn Smith, Ph.D., to Board of Directors and Expands Strategic and Scientific Advisory Leadership
content:https://www.prnewswire.com/news-releases/therna-biosciences-appoints-biotech-veteran-devyn-smith-phd-to-board-of-directors-and-expands-strategic-and-scientific-advisory-leadership-302695275.htmlSOURCE
More news about: Therna Biosciences
Feb 24, 2026, 08:30 ET Caris Launches Proprietary AI Insights Signature Which Deepens Understanding of Response to Breast Cancer Patients' Oral Chemotherapy Drug
David Spetzler, MS, PhD, MBA. "Caris AI Insights help researchers and clinicians provide a valuable molecular blueprint of a patient's tumor biology and is another way Caris'
More news about: Caris Life Sciences
Feb 24, 2026, 08:01 ET START Appoints Dr. Frank Smith President of its XenoSTART Preclinical Research Business Unit
Frank Smith, PhD, MBA, as President of
More news about: The START Center for Cancer Research
Feb 24, 2026, 08:00 ET K36 Therapeutics Highlights First-in-Human KTX-2001 Prostate Cancer Study Design at American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2026
design evaluating KTX-2001, an oral, first-in-class NSD2/MMSET inhibitor, in metastatic castration-resistant prostate cancer," said Wassim Abida, MD, PhD, of Memorial Sloan Kettering Cancer Center. "Preclinical findings support the rationale for targeting NSD2 in prostate cancer, where it has been associated
More news about: K36 Therapeutics
Feb 24, 2026, 08:00 ET CereVasc, Inc. Announces Publication of a Multi-Center Study Evaluating the eShunt® System in the Treatment of Patients with NPH
system concept originated from Tufts Medical Center physicians Carl Heilman, MD, Neurosurgeon and Chair Emeritus of Neurosurgery, and Adel Malek, MD, PhD, Chief of Neurovascular Surgery and Director of Cerebrovascular and Endovascular Neurosurgery. The patented eShunt System includes an endovascularly
More news about: CereVasc
Feb 24, 2026, 07:30 ET Keenova Unveils Clinical Data from Phase 2 Plantar Fibromatosis Study at the ACFAS Annual Meeting
(PFI)Authors: C. James Anderson, DPM; Jason Levy, DPM, FACFAS; Sara E. Suttle, DPM, FACFAS; Nigel Jones, PharmD; Luis Ortega, MD; Gongfu Zhou, PhD; Joseph Caporusso, DPMAbout Plantar FibromatosisPlantar fibromatosis or Ledderhose disease is a hyperproliferative fibrous
More news about: Keenova Therapeutics
Feb 24, 2026, 07:05 ET Hearing Loss in Children: ASHA, EAA Stress Importance of Prevention and Early Intervention This World Hearing Day
hearing loss, we want families to know that early detection and intervention can offer life-changing benefits," said 2026 EAA President Aurora J. Weaver, PhD, AuD, CCC-A. "Services provided by educational audiologists ensure that children ages birth to 21 who are deaf or heard of hearing have the tools they
More news about: American Speech-Language-Hearing Association (ASHA)
Feb 24, 2026, 04:00 ET Five Trailblazing Women Scientists from the Global South Receive 2026 OWSD-Elsevier Foundation Award for Sustainable Energy
10,500 members and runs various programs, including the PhD fellowship programme with over 400 successful graduates from Least Developed Countries and sub-Saharan Africa, as well as an
More news about: The Elsevier Foundation
Feb 23, 2026, 17:02 ET Microplastics Discovered in Prostate Tumors
Albergamo, NYU Langone researchers involved in the study are Leonardo Trasande, MD, MPP; Trevor Johnson, PhD; Fang-Ming Deng, MD, PhD; Mark Strong, DO; David Wise, MD, PhD; José Alemán, MD, PhD; Zixuan Mo, BS; Mariana Rangel Camacho, BS; Nataliya Byrne, BA; Tatiana Sanchez Nolasco, MPH; Adrian Rivera,
More news about: NYU Grossman School of Medicine and NYU Langone Health
Feb 23, 2026, 16:00 ET New ACVIM Consensus Statement Highlights Visbiome Vet's De Simone Formulation in Diet-First Approach
central role of diet in managing chronic enteropathy but also the potential value of microbiome-directed interventions," said Dr. Albert Jergens, DVM, PhD, DACVIM, Iowa State University College of Veterinary Medicine. "With Visbiome Vet, clinicians have access to a probiotic supported by randomized clinical
More news about: ExeGi Pharma